approval · primary record
LEVOCETIRIZINE DIHYDROCHLORIDE
FDA · NDA · 2025-07-11
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2025-07-11 |
| Brand | XYZAL |
| Sponsor | CHATTEM SANOFI |
| Route | ORAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T03:31:05.325Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:LEVOCETIRIZINE DIHYDROCHLORIDE:2025-07-11
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.